Report Detail

Pharma & Healthcare Global Over-The-Counter (OTC) Drugs Market Insights and Forecast to 2026

  • RnM4151357
  • |
  • 21 August, 2020
  • |
  • Global
  • |
  • 111 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Over-The-Counter (OTC) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Over-The-Counter (OTC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Over-The-Counter (OTC) Drugs market is segmented into
Cold and Flu Products
Analgesics
Dermatological Products
Gastrointestinal Products
Vitamin
Other

Segment by Application, the Over-The-Counter (OTC) Drugs market is segmented into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Regional and Country-level Analysis
The Over-The-Counter (OTC) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Over-The-Counter (OTC) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Over-The-Counter (OTC) Drugs Market Share Analysis
Over-The-Counter (OTC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over-The-Counter (OTC) Drugs business, the date to enter into the Over-The-Counter (OTC) Drugs market, Over-The-Counter (OTC) Drugs product introduction, recent developments, etc.

The major vendors covered:
Bayer
Boehringer Ingelheim
GSK
Novartis
Pfizer
PGT healthcare
Sanofi
Teva Pharmaceuticals
Takeda
Cipla
Sun Pharmaceutical Industries
Glenmark
Innovus Pharmaceuticals


1 Study Coverage

  • 1.1 Over-The-Counter (OTC) Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Over-The-Counter (OTC) Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Type
    • 1.4.2 Cold and Flu Products
    • 1.4.3 Analgesics
    • 1.4.4 Dermatological Products
    • 1.4.5 Gastrointestinal Products
    • 1.4.6 Vitamin
    • 1.4.7 Other
  • 1.5 Market by Application
    • 1.5.1 Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Application
    • 1.5.2 Hospital Pharmacy
    • 1.5.3 Retail Pharmacy
    • 1.5.4 Online Pharmacy
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Over-The-Counter (OTC) Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Over-The-Counter (OTC) Drugs Revenue 2015-2026
    • 2.1.2 Global Over-The-Counter (OTC) Drugs Sales 2015-2026
  • 2.2 Global Over-The-Counter (OTC) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Over-The-Counter (OTC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Over-The-Counter (OTC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Over-The-Counter (OTC) Drugs Competitor Landscape by Players

  • 3.1 Over-The-Counter (OTC) Drugs Sales by Manufacturers
    • 3.1.1 Over-The-Counter (OTC) Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Over-The-Counter (OTC) Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Over-The-Counter (OTC) Drugs Revenue by Manufacturers
    • 3.2.1 Over-The-Counter (OTC) Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Over-The-Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Over-The-Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Over-The-Counter (OTC) Drugs Revenue in 2019
    • 3.2.5 Global Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Over-The-Counter (OTC) Drugs Price by Manufacturers
  • 3.4 Over-The-Counter (OTC) Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Over-The-Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Over-The-Counter (OTC) Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Over-The-Counter (OTC) Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Over-The-Counter (OTC) Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Over-The-Counter (OTC) Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Over-The-Counter (OTC) Drugs Revenue by Type (2015-2020)
    • 4.1.3 Over-The-Counter (OTC) Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Over-The-Counter (OTC) Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Over-The-Counter (OTC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Over-The-Counter (OTC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Over-The-Counter (OTC) Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Over-The-Counter (OTC) Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Over-The-Counter (OTC) Drugs Revenue by Application (2015-2020)
    • 5.1.3 Over-The-Counter (OTC) Drugs Price by Application (2015-2020)
  • 5.2 Over-The-Counter (OTC) Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Over-The-Counter (OTC) Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Over-The-Counter (OTC) Drugs by Country
    • 6.1.1 North America Over-The-Counter (OTC) Drugs Sales by Country
    • 6.1.2 North America Over-The-Counter (OTC) Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Over-The-Counter (OTC) Drugs Market Facts & Figures by Type
  • 6.3 North America Over-The-Counter (OTC) Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Over-The-Counter (OTC) Drugs by Country
    • 7.1.1 Europe Over-The-Counter (OTC) Drugs Sales by Country
    • 7.1.2 Europe Over-The-Counter (OTC) Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Over-The-Counter (OTC) Drugs Market Facts & Figures by Type
  • 7.3 Europe Over-The-Counter (OTC) Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Over-The-Counter (OTC) Drugs by Region
    • 8.1.1 Asia Pacific Over-The-Counter (OTC) Drugs Sales by Region
    • 8.1.2 Asia Pacific Over-The-Counter (OTC) Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Over-The-Counter (OTC) Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Over-The-Counter (OTC) Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Over-The-Counter (OTC) Drugs by Country
    • 9.1.1 Latin America Over-The-Counter (OTC) Drugs Sales by Country
    • 9.1.2 Latin America Over-The-Counter (OTC) Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Over-The-Counter (OTC) Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Over-The-Counter (OTC) Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Over-The-Counter (OTC) Drugs by Country
    • 10.1.1 Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country
    • 10.1.2 Middle East and Africa Over-The-Counter (OTC) Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Over-The-Counter (OTC) Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Over-The-Counter (OTC) Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Description and Business Overview
    • 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer Over-The-Counter (OTC) Drugs Products Offered
    • 11.1.5 Bayer Related Developments
  • 11.2 Boehringer Ingelheim
    • 11.2.1 Boehringer Ingelheim Corporation Information
    • 11.2.2 Boehringer Ingelheim Description and Business Overview
    • 11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Products Offered
    • 11.2.5 Boehringer Ingelheim Related Developments
  • 11.3 GSK
    • 11.3.1 GSK Corporation Information
    • 11.3.2 GSK Description and Business Overview
    • 11.3.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 GSK Over-The-Counter (OTC) Drugs Products Offered
    • 11.3.5 GSK Related Developments
  • 11.4 Novartis
    • 11.4.1 Novartis Corporation Information
    • 11.4.2 Novartis Description and Business Overview
    • 11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Novartis Over-The-Counter (OTC) Drugs Products Offered
    • 11.4.5 Novartis Related Developments
  • 11.5 Pfizer
    • 11.5.1 Pfizer Corporation Information
    • 11.5.2 Pfizer Description and Business Overview
    • 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Pfizer Over-The-Counter (OTC) Drugs Products Offered
    • 11.5.5 Pfizer Related Developments
  • 11.6 PGT healthcare
    • 11.6.1 PGT healthcare Corporation Information
    • 11.6.2 PGT healthcare Description and Business Overview
    • 11.6.3 PGT healthcare Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 PGT healthcare Over-The-Counter (OTC) Drugs Products Offered
    • 11.6.5 PGT healthcare Related Developments
  • 11.7 Sanofi
    • 11.7.1 Sanofi Corporation Information
    • 11.7.2 Sanofi Description and Business Overview
    • 11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Sanofi Over-The-Counter (OTC) Drugs Products Offered
    • 11.7.5 Sanofi Related Developments
  • 11.8 Teva Pharmaceuticals
    • 11.8.1 Teva Pharmaceuticals Corporation Information
    • 11.8.2 Teva Pharmaceuticals Description and Business Overview
    • 11.8.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Products Offered
    • 11.8.5 Teva Pharmaceuticals Related Developments
  • 11.9 Takeda
    • 11.9.1 Takeda Corporation Information
    • 11.9.2 Takeda Description and Business Overview
    • 11.9.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Takeda Over-The-Counter (OTC) Drugs Products Offered
    • 11.9.5 Takeda Related Developments
  • 11.10 Cipla
    • 11.10.1 Cipla Corporation Information
    • 11.10.2 Cipla Description and Business Overview
    • 11.10.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Cipla Over-The-Counter (OTC) Drugs Products Offered
    • 11.10.5 Cipla Related Developments
  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Description and Business Overview
    • 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer Over-The-Counter (OTC) Drugs Products Offered
    • 11.1.5 Bayer Related Developments
  • 11.12 Glenmark
    • 11.12.1 Glenmark Corporation Information
    • 11.12.2 Glenmark Description and Business Overview
    • 11.12.3 Glenmark Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Glenmark Products Offered
    • 11.12.5 Glenmark Related Developments
  • 11.13 Innovus Pharmaceuticals
    • 11.13.1 Innovus Pharmaceuticals Corporation Information
    • 11.13.2 Innovus Pharmaceuticals Description and Business Overview
    • 11.13.3 Innovus Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Innovus Pharmaceuticals Products Offered
    • 11.13.5 Innovus Pharmaceuticals Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Over-The-Counter (OTC) Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Over-The-Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Over-The-Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Over-The-Counter (OTC) Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Over-The-Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Over-The-Counter (OTC) Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Over-The-Counter (OTC) Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Over-The-Counter (OTC) Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Over-The-Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Over-The-Counter (OTC) Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Over-The-Counter (OTC) Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Over-The-Counter (OTC) Drugs. Industry analysis & Market Report on Over-The-Counter (OTC) Drugs is a syndicated market report, published as Global Over-The-Counter (OTC) Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Over-The-Counter (OTC) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,116.10
    4,674.15
    6,232.20
    3,623.10
    5,434.65
    7,246.20
    607,542.00
    911,313.00
    1,215,084.00
    325,806.00
    488,709.00
    651,612.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report